NDC 25021-301

adenosine

Adenosine

adenosine is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Adenosine.

Product ID25021-301_4bc1196f-288a-42ee-a47b-465c23f607e5
NDC25021-301
Product TypeHuman Prescription Drug
Proprietary Nameadenosine
Generic NameAdenosine
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2014-04-16
Marketing CategoryANDA / ANDA
Application NumberANDA077283
Labeler NameSagent Pharmaceuticals
Substance NameADENOSINE
Active Ingredient Strength3 mg/mL
Pharm ClassesAdenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 25021-301-67

10 SYRINGE in 1 CARTON (25021-301-67) > 2 mL in 1 SYRINGE
Marketing Start Date2014-04-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 25021-301-72 [25021030172]

adenosine INJECTION
Marketing CategoryANDA
Application NumberANDA077283
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-12-01
Marketing End Date2014-08-31

NDC 25021-301-02 [25021030102]

adenosine INJECTION
Marketing CategoryANDA
Application NumberANDA078686
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-09-01
Marketing End Date2019-02-01

NDC 25021-301-68 [25021030168]

adenosine INJECTION
Marketing CategoryANDA
Application NumberANDA077283
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-04-16

NDC 25021-301-04 [25021030104]

adenosine INJECTION
Marketing CategoryANDA
Application NumberANDA078686
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2009-09-01
Marketing End Date2019-02-01

NDC 25021-301-67 [25021030167]

adenosine INJECTION
Marketing CategoryANDA
Application NumberANDA077283
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-04-16

NDC 25021-301-76 [25021030176]

adenosine INJECTION
Marketing CategoryANDA
Application NumberANDA077283
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2007-12-01
Marketing End Date2014-08-31

Drug Details

Active Ingredients

IngredientStrength
ADENOSINE3 mg/mL

OpenFDA Data

SPL SET ID:5a55b45d-9cee-4c0c-9e44-021dbf70a018
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 727355
  • 727360
  • UPC Code
  • 0325021301678
  • Pharmacological Class

    • Adenosine Receptor Agonist [EPC]
    • Adenosine Receptor Agonists [MoA]

    NDC Crossover Matching brand name "adenosine" or generic name "Adenosine"

    NDCBrand NameGeneric Name
    0404-9809AdenosineAdenosine
    0409-1932AdenosineADENOSINE
    0641-6113AdenosineAdenosine
    0703-8776AdenosineAdenosine
    0703-8777AdenosineAdenosine
    10019-063AdenosineADENOSINE
    16714-180AdenosineAdenosine
    16714-556AdenosineAdenosine
    16714-972AdenosineAdenosine
    16714-997AdenosineAdenosine
    17478-542AdenosineAdenosine
    17478-544AdenosineAdenosine
    17478-953AdenosineAdenosine
    23155-258AdenosineAdenosine
    23155-259AdenosineAdenosine
    25021-301adenosineadenosine
    68083-101AdenosineAdenosine
    68083-157AdenosineAdenosine
    68083-156AdenosineAdenosine
    70518-1232AdenosineAdenosine
    71872-7035AdenosineAdenosine
    50090-1548AdenosineAdenosine
    51662-1345ADENOSINEADENOSINE
    52584-026AdenosineAdenosine
    55150-192AdenosineAdenosine
    55150-193AdenosineAdenosine
    55154-1279AdenosineAdenosine
    55648-630ADENOSINEADENOSINE
    63323-651AdenosineAdenosine
    64679-630ADENOSINEADENOSINE
    67457-856AdenosineAdenosine
    67457-854adenosineadenosine
    67457-855adenosineadenosine
    67457-857AdenosineAdenosine
    71872-7099AdenosineAdenosine
    67457-859AdenosineAdenosine
    67457-858AdenosineAdenosine
    51662-1450ADENOSINEADENOSINE
    0469-8234Adenocardadenosine
    42491-1200Tissen ICM 10Adenosine
    42491-1100Tissen NF 10Adenosine

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.